Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters











Database
Language
Publication year range
1.
Transl Psychiatry ; 6(8): e873, 2016 08 23.
Article in English | MEDLINE | ID: mdl-27552586

ABSTRACT

Posttraumatic stress disorder is characterized by hyperarousal, sensory processing impairments, sleep disturbances and altered fear regulation; phenotypes associated with changes in brain oscillatory activity. Molecules associated with activity-dependent plasticity, including brain-derived neurotrophic factor (BDNF), may regulate neural oscillations by controlling synaptic activity. BDNF synthesis includes production of multiple Bdnf transcripts, which contain distinct 5' noncoding exons. We assessed arousal, sensory processing, fear regulation and sleep in animals where BDNF expression from activity-dependent promoter IV is disrupted (Bdnf-e4 mice). Bdnf-e4 mice display sensory hyper-reactivity and impaired electrophysiological correlates of sensory information processing as measured by event-related potentials (ERP). Utilizing electroencephalogram, we identified a decrease in slow-wave activity during non-rapid eye movement sleep, suggesting impaired sleep homeostasis. Fear extinction is controlled by hippocampal-prefrontal cortical BDNF signaling, and neurophysiological communication patterns between the hippocampus (HPC) and medial prefrontal cortex (mPFC) correlate with behavioral performance during extinction. Impaired fear extinction in Bdnf-e4 mice is accompanied by increased HPC activation and decreased HPC-mPFC theta phase synchrony during early extinction, as well as increased mPFC activation during extinction recall. These results suggest that activity-dependent BDNF signaling is critical for regulating oscillatory activity, which may contribute to altered behavior.


Subject(s)
Arousal/genetics , Brain Waves/genetics , Brain-Derived Neurotrophic Factor/genetics , Evoked Potentials/genetics , Sleep/genetics , Stress Disorders, Post-Traumatic/genetics , Animals , Arousal/physiology , Brain Waves/physiology , Brain-Derived Neurotrophic Factor/metabolism , Electroencephalography , Evoked Potentials/physiology , Extinction, Psychological/physiology , Fear/physiology , Hippocampus/physiopathology , Mice , Prefrontal Cortex/physiopathology , Prepulse Inhibition , Promoter Regions, Genetic , Reflex, Startle , Sleep/physiology , Stress Disorders, Post-Traumatic/physiopathology , Theta Rhythm/genetics , Theta Rhythm/physiology
2.
Pharmacopsychiatry ; 46(1): 10-5, 2013 Jan.
Article in English | MEDLINE | ID: mdl-22592505

ABSTRACT

INTRODUCTION: Here, we present a stem-cell based study on the de-novo generation of beta-III-tubulin-positive neurons after treatment with the classic antipsychotic drug haloperidol or after treatment with the second-generation antipsychotic (SGA) ziprasidone. METHODS: Adult neural stem cells (ANSC) dissociated from the adult mouse hippocampus were expanded in cell culture with basic fibroblast growth factor (bFGF) and epidermal growth factor (EGF). ANSC differentiated upon withdrawal of EGF and bFGF. RESULTS AND DISCUSSION: Ziprasidone generated significantly more beta-III-tubulin-positive neurons than haloperidol during the differentiation of adult neural stem cells isolated from murine hippocampus (ANSC). We assume that this net increase in neurogenesis by ziprasidone relies on this drug's 5-HT1A receptor affinity, which is not present in the haloperidol molecule, since the inactivation by WAY100621 impeded this process. These data could possibly suggest a clinical relevance for studying antipsychotic drugs in the stem cell paradigm employed in this study.


Subject(s)
Antipsychotic Agents/pharmacology , Haloperidol/pharmacology , Hippocampus/cytology , Neural Stem Cells/drug effects , Neurogenesis/drug effects , Piperazines/pharmacology , Thiazoles/pharmacology , Animals , Cell Differentiation/drug effects , Cell Movement/drug effects , Cells, Cultured , Epidermal Growth Factor/pharmacology , Fibroblast Growth Factor 2/pharmacology , Hippocampus/drug effects , Immunohistochemistry , Mice , Mice, Inbred C57BL , Receptor, Serotonin, 5-HT1A/drug effects , Serotonin Antagonists/pharmacology , Tubulin/biosynthesis
3.
Mol Psychiatry ; 15(12): 1152-63, 2010 Dec.
Article in English | MEDLINE | ID: mdl-20308988

ABSTRACT

The subgranular zone of the adult hippocampal dentate gyrus contains a pool of neural stem cells that continuously divide and differentiate into functional granule cells. It has been shown that production of new hippocampal neurons is necessary for amelioration of stress-induced behavioral changes by antidepressants in animal models of depression. The survival of newly born hippocampal neurons is decreased by chronic psychosocial stress and increased by exposure to enriched environments. These observations suggest the existence of a link between hippocampal neurogenesis, stress-induced behavioral changes, and the beneficial effects of enriched environment. To show causality, we subjected transgenic mice with conditionally suppressed neurogenesis to psychosocial stress followed by environmental enrichment. First, we showed that repeated social defeat coupled with chronic exposure to an aggressor produces robust and quantifiable indices of submissive and depressive-like behaviors; second, subsequent exposure to an enriched environment led to extinction of the submissive phenotype, while animals exposed to an impoverished environment retained the submissive phenotype; and third, enrichment was not effective in reversing the submissive and depressive-like behaviors in transgenic mice lacking neurogenesis. Our data show two main findings. First, living in an enriched environment is highly effective in extinguishing submissive behavioral traits developed during chronic social stress, and second, these effects are critically dependent on adult neurogenesis, indicating that beneficial behavioral adaptations are dependent on intact adult neurogenesis.


Subject(s)
Adaptation, Physiological , Adult Stem Cells/cytology , Environment , Neural Stem Cells/cytology , Neurogenesis/physiology , Stress, Psychological/psychology , Adaptation, Psychological , Adult Stem Cells/physiology , Analysis of Variance , Animals , Cell Differentiation , Cell Tracking/methods , Dentate Gyrus/cytology , Depression/physiopathology , Depression/psychology , Disease Models, Animal , Dominance-Subordination , Female , Housing, Animal , Male , Mice , Mice, Inbred C57BL , Mice, Transgenic , Neural Stem Cells/physiology , Resilience, Psychological , Stress, Psychological/physiopathology
4.
Mol Psychiatry ; 13(9): 858-72, 2008 Sep.
Article in English | MEDLINE | ID: mdl-18332879

ABSTRACT

The glutamate receptor 6 (GluR6 or GRIK2, one of the kainate receptors) gene resides in a genetic linkage region (6q21) associated with bipolar disorder (BPD), but its function in affective regulation is unknown. Compared with wild-type (WT) and GluR5 knockout (KO) mice, GluR6 KO mice were more active in multiple tests and super responsive to amphetamine. In a battery of specific tests, GluR6 KO mice also exhibited less anxious or more risk-taking type behavior and less despair-type manifestations, and they also had more aggressive displays. Chronic treatment with lithium, a classic antimanic mood stabilizer, reduced hyperactivity, aggressive displays and some risk-taking type behavior in GluR6 KO mice. Hippocampal and prefrontal cortical membrane levels of GluR5 and KA-2 receptors were decreased in GluR6 KO mice, and chronic lithium treatment did not affect these decreases. The membrane levels of other glutamatergic receptors were not significantly altered by GluR6 ablation or chronic lithium treatment. Together, these biochemical and behavioral results suggest a unique role for GluR6 in controlling abnormalities related to the behavioral symptoms of mania, such as hyperactivity or psychomotor agitation, aggressiveness, driven or increased goal-directed pursuits, risk taking and supersensitivity to psychostimulants. Whether GluR6 perturbation is involved in the mood elevation or thought disturbance of mania and the cyclicity of BPD are unknown. The molecular mechanism underlying the behavioral effects of lithium in GluR6 KO mice remains to be elucidated.


Subject(s)
Bipolar Disorder/metabolism , Receptors, Kainic Acid/metabolism , Analysis of Variance , Animals , Antimanic Agents/therapeutic use , Avoidance Learning/drug effects , Behavioral Symptoms , Bipolar Disorder/drug therapy , Bipolar Disorder/genetics , Bipolar Disorder/physiopathology , Exploratory Behavior/drug effects , Interpersonal Relations , Lithium Carbonate/therapeutic use , Maze Learning/drug effects , Mice , Mice, Inbred C57BL , Mice, Knockout , Receptors, Kainic Acid/deficiency , Risk-Taking , Swimming , Time Factors , GluK2 Kainate Receptor
SELECTION OF CITATIONS
SEARCH DETAIL